Literature DB >> 6419896

Effect of digoxin and vitamin E in preventing cardiac damage caused by doxorubicin in acute myeloid leukaemia.

J A Whittaker, S A Al-Ismail.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6419896      PMCID： PMC1444076          DOI： 10.1136/bmj.288.6413.283-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Adriamycin: amelioration of toxicity by alpha-tocopherol.

Authors:  C E Myers; W McGuire; R Young
Journal:  Cancer Treat Rep       Date:  1976-07

2.  Bedside technics for the evaluation of ventricular function in man.

Authors:  A M Weissler; W S Harris; C D Schoenfeld
Journal:  Am J Cardiol       Date:  1969-04       Impact factor: 2.778

3.  Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia.

Authors:  S Al-Ismail; J A Whittaker
Journal:  Br Med J       Date:  1979-05-26

4.  Risk factors for doxorubicin-induced congestive heart failure.

Authors:  D D Von Hoff; M W Layard; P Basa; H L Davis; A L Von Hoff; M Rozencweig; F M Muggia
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391
  4 in total
  6 in total

Review 1.  Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy.

Authors:  Akiko Nakayama; Karen P Alladin; Obianuju Igbokwe; Jeffrey D White
Journal:  Cancer Invest       Date:  2011-12       Impact factor: 2.176

Review 2.  Minimising the long-term adverse effects of childhood leukaemia therapy.

Authors:  Claudia Langebrake; Dirk Reinhardt; Jörg Ritter
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Cardioprotective interventions for cancer patients receiving anthracyclines.

Authors:  Elvira C van Dalen; Huib N Caron; Heather O Dickinson; Leontien Cm Kremer
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

4.  Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial.

Authors:  Wei Hao; Sheng Liu; Yuenong Qin; Chenping Sun; Liying Chen; Chunyu Wu; Yijia Bao
Journal:  Trials       Date:  2017-08-22       Impact factor: 2.279

5.  CYP1B1 as a therapeutic target in cardio-oncology.

Authors:  Alexa N Carrera; Marianne K O Grant; Beshay N Zordoky
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

6.  Platycodon grandiflorum Protects Against Anthracycline-Induced Cardiotoxicity in Early Breast Cancer Patients.

Authors:  Wei Hao; Youyang Shi; Yuenong Qin; Chenping Sun; Liying Chen; Chunyu Wu; Yijia Bao; Sheng Liu
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.